Cargando…
Risk of cognitive impairment in men with advanced prostate cancer treated with NHAs: A systematic review and network meta‐analysis
Novel hormonal agents (NHAs) have significantly improved outcomes in men with advanced prostate cancer. However, it remains unclear whether NHAs are associated with subsequent cognitive impairment. Thus, we sought to perform a network meta‐analysis to compare the risk of cognitive impairment across...
Autores principales: | Huang, Shi‐Wei, Chen, Li‐Chin, Tseng, Chi‐Shin, Chen, Chung‐Hsin, Yuan, Lun‐Hsiang, Shau, Wen‐Yi, Pu, Yeong‐Shiau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926078/ https://www.ncbi.nlm.nih.gov/pubmed/36369801 http://dx.doi.org/10.1111/cts.13451 |
Ejemplares similares
-
Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms
por: Chen, Chung-Hsin, et al.
Publicado: (2023) -
Achieving NHAS 90/90/80 Objectives by 2020: An Interactive Tool Modeling Local HIV Prevalence Projections
por: Kelly, Jane M., et al.
Publicado: (2016) -
Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer
por: Tseng, Chi-Shin, et al.
Publicado: (2023) -
Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
por: Tseng, Chi-Shin, et al.
Publicado: (2021) -
Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study
por: Chiang, I-Ni, et al.
Publicado: (2017)